(Q42256538)

19 October 2017

title

Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice (English)

1 reference

19 October 2017

1 reference

1 reference

Craig J van Dolleweerd

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Julian Ma

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Elena Stylianou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Gil R Diogo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Ilaria Pepponi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Mauricio A Arias

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Christopher C Rider

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Laura Sibley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Simon M Cutting

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Andrew Loxley

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Rajko Reljic

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Camille Locht

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

1 February 2014

1 reference

European Journal of Immunology

19 October 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

440-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214530%20AND%20SRC:MED&resulttype=core&format=json

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

The perfect mix: recent progress in adjuvant research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Adjuvants in tuberculosis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Peripheral deletion of antigen-reactive T cells in oral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Is the development of a new tuberculosis vaccine possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Immunological aspects of polymer microsphere vaccine delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

A novel human IgA monoclonal antibody protects against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

inferred from DOI database lookup

7 January 2021

based on heuristic

Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887

inferred from DOI database lookup

7 January 2021

based on heuristic

Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343887